Catalyst Wire Dossier Catalyst Wire Dossier

GP0122

· Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP0122, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area [NA]

See pricing